Agilon Health, Inc. (NYSE:AGL - Get Free Report) has been given a consensus rating of "Hold" by the seventeen analysts that are currently covering the firm, Marketbeat.com reports. Two research analysts have rated the stock with a sell rating, ten have issued a hold rating and five have issued a buy rating on the company. The average 1-year price objective among analysts that have issued a report on the stock in the last year is $4.0769.
A number of brokerages recently weighed in on AGL. Citigroup upgraded Agilon Health from a "neutral" rating to a "buy" rating and upped their price objective for the stock from $3.25 to $5.00 in a research note on Friday, April 25th. JMP Securities restated a "market perform" rating on shares of Agilon Health in a research note on Monday, April 28th. Cowen restated a "hold" rating on shares of Agilon Health in a research note on Tuesday, April 15th. Robert W. Baird decreased their price objective on Agilon Health from $6.00 to $5.00 and set a "neutral" rating for the company in a research note on Tuesday, April 15th. Finally, Benchmark decreased their price target on Agilon Health from $4.00 to $1.50 and set a "buy" rating for the company in a research note on Wednesday.
Get Our Latest Stock Report on AGL
Agilon Health Trading Down 0.4%
Shares of AGL traded down $0.00 during midday trading on Thursday, reaching $0.87. 30,405,277 shares of the stock were exchanged, compared to its average volume of 15,618,723. Agilon Health has a 52 week low of $0.71 and a 52 week high of $6.08. The company's 50 day moving average is $2.08 and its two-hundred day moving average is $3.15. The company has a market capitalization of $361.33 million, a P/E ratio of -1.13 and a beta of 0.14.
Agilon Health (NYSE:AGL - Get Free Report) last issued its quarterly earnings data on Monday, August 4th. The company reported ($0.25) earnings per share for the quarter, missing analysts' consensus estimates of ($0.11) by ($0.14). The company had revenue of $1.39 billion for the quarter, compared to analysts' expectations of $1.47 billion. Agilon Health had a negative return on equity of 66.76% and a negative net margin of 5.35%. The company's revenue for the quarter was down 5.9% compared to the same quarter last year. During the same quarter last year, the company earned ($0.07) earnings per share. On average, sell-side analysts expect that Agilon Health will post -0.59 EPS for the current year.
Institutional Inflows and Outflows
Several institutional investors have recently modified their holdings of the company. Captrust Financial Advisors raised its stake in shares of Agilon Health by 10.9% in the fourth quarter. Captrust Financial Advisors now owns 35,485 shares of the company's stock worth $67,000 after purchasing an additional 3,494 shares during the last quarter. Signaturefd LLC grew its holdings in Agilon Health by 28.3% during the first quarter. Signaturefd LLC now owns 18,461 shares of the company's stock worth $80,000 after acquiring an additional 4,073 shares during the period. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. grew its holdings in Agilon Health by 2.5% during the fourth quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 206,991 shares of the company's stock worth $393,000 after acquiring an additional 5,107 shares during the period. Wealth Enhancement Advisory Services LLC grew its holdings in Agilon Health by 5.6% during the second quarter. Wealth Enhancement Advisory Services LLC now owns 105,324 shares of the company's stock worth $256,000 after acquiring an additional 5,627 shares during the period. Finally, State of Wyoming grew its holdings in Agilon Health by 4.9% during the first quarter. State of Wyoming now owns 128,509 shares of the company's stock worth $556,000 after acquiring an additional 6,005 shares during the period.
Agilon Health Company Profile
(
Get Free Report)
agilon health, inc. provides healthcare services for seniors through primary care physicians in the communities of the United States. It offers a platform that manages the total healthcare needs of the patients by subscription-like per-member per-month. The company was formerly known as Agilon Health Topco, Inc and changed its name to agilon health, inc.
Recommended Stories

Before you consider Agilon Health, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Agilon Health wasn't on the list.
While Agilon Health currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
MarketBeat's analysts have just released their top five short plays for September 2025. Learn which stocks have the most short interest and how to trade them. Enter your email address to see which companies made the list.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.